Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1919.3550.75 (+2.72 %)

PREV CLOSE ( ) 1868.60

OPEN PRICE ( ) 1849.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3170

TODAY'S LOW / HIGH ( )1849.25 1929.00

52 WK LOW / HIGH ( )1200 2130

NSE1921.0042.9 (+2.28 %)

PREV CLOSE( ) 1878.10

OPEN PRICE ( ) 1878.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1921.00 (119)

VOLUME 431248

TODAY'S LOW / HIGH( ) 1871.50 1930.00

52 WK LOW / HIGH ( )1277.8 2131

Chairman	Srinivas Sadu
Company Secretary	Sampath Kumar Pallerlamudi
Non Executive Independent Director	Naina Lal Kidwai Udo Jahannes Vetter Satyanarayana Murthy Chavali Essaji Goolam Vahanvati
Non Independent & Non Executive Director	Allen Zhang Wenjie Zhang Wei Huang

Incorporation Year : 20-03 1978

Registered Office :

Address : Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal-gandimaisamma Mandal,Medchal- Malkajgiri District Hyderabad,
Telangana-500043 .

Phone : 040 30510999

Email : gland@glandpharma.com / investor@glandpharma.com

URL : www.glandpharma.com

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

Risk Disclosures on Derivatives

Company Information

GLAND PHARMA LTD.